UK's John Wilkinson takes on strategic new role in rationalized regulatory oversight system
This article was originally published in Clinica
Executive Summary
John Wilkinson, director of devices at the UK’s Medicines and Healthcare Products Regulatory Agency, has taken on a vital new role in continuing to optimize collaboration and cooperation among member state competent authorities responsible for the regulation of medical devices.